Abstract
Phosphodiesterase 10A (PDE10A) is a recently identified member of the cyclic nucleotide phosphodiesterase family. PDE10A is notable in that it has a relatively restricted distribution: PDE10A mRNA and protein are expressed primarily in the dopaminoreceptive medium spiny neurons of the striatum. Potent and selective PDE10A inhibitors have recently been described in the scientific literature and their in vivo effects suggest the potential uses of PDE10A inhibitors in CNS disorders, particularly schizophrenia. This article provides a brief overview of the presently available scientific literature as well as recent meeting presentations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
